| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |